Further experience with regional radiofrequency hyperthermia and cytotoxic chemotherapy for unresectable hepatic neoplasia

Frederick L Moffat, T. Gilas, K. Calhoun, M. Falk, R. Dalfen, L. E. Rotstein, L. Makowka, V. Howard, D. Laing, D. Venturi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The authors report on 178 patients with unresectable hepatic tumors who have been treated with 1 to 25 (median, 6) courses of radiofrequency hyperthermia (RFHT) and chemotherapy. In 137 patients, the hepatic tumors consisted of metastases from colorectal adenocarcinomas. For patients who had no previous therapy and who had colorectal metastases with no extrahepatic disease, cumulative survival at 52 weeks' follow-up was 80.5% and partial tumor regression was seen in 78.4%. Among the 69 patients who previously had conventional treatment for their hepatic disease, partial regression was seen in 43.5%. We are no longer monitoring tumor core temperature routinely, as the invasive methods currently in use yield irreproducible results; the risks to the patient cannot be justified in view of the questionable relevance of the data obtained. A prospective randomized study of systemic chemotherapy with or without RFHT in patients with colorectal hepatic metastases is in progress.

Original languageEnglish
Pages (from-to)1291-1295
Number of pages5
JournalCancer
Volume55
Issue number6
DOIs
StatePublished - Jun 5 1985
Externally publishedYes

Fingerprint

Fever
Drug Therapy
Liver
Neoplasms
Neoplasm Metastasis
Adenocarcinoma
Prospective Studies
Temperature
Survival
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Further experience with regional radiofrequency hyperthermia and cytotoxic chemotherapy for unresectable hepatic neoplasia. / Moffat, Frederick L; Gilas, T.; Calhoun, K.; Falk, M.; Dalfen, R.; Rotstein, L. E.; Makowka, L.; Howard, V.; Laing, D.; Venturi, D.

In: Cancer, Vol. 55, No. 6, 05.06.1985, p. 1291-1295.

Research output: Contribution to journalArticle

Moffat, Frederick L ; Gilas, T. ; Calhoun, K. ; Falk, M. ; Dalfen, R. ; Rotstein, L. E. ; Makowka, L. ; Howard, V. ; Laing, D. ; Venturi, D. / Further experience with regional radiofrequency hyperthermia and cytotoxic chemotherapy for unresectable hepatic neoplasia. In: Cancer. 1985 ; Vol. 55, No. 6. pp. 1291-1295.
@article{8424fa803b4d4edda42de6de49690cee,
title = "Further experience with regional radiofrequency hyperthermia and cytotoxic chemotherapy for unresectable hepatic neoplasia",
abstract = "The authors report on 178 patients with unresectable hepatic tumors who have been treated with 1 to 25 (median, 6) courses of radiofrequency hyperthermia (RFHT) and chemotherapy. In 137 patients, the hepatic tumors consisted of metastases from colorectal adenocarcinomas. For patients who had no previous therapy and who had colorectal metastases with no extrahepatic disease, cumulative survival at 52 weeks' follow-up was 80.5{\%} and partial tumor regression was seen in 78.4{\%}. Among the 69 patients who previously had conventional treatment for their hepatic disease, partial regression was seen in 43.5{\%}. We are no longer monitoring tumor core temperature routinely, as the invasive methods currently in use yield irreproducible results; the risks to the patient cannot be justified in view of the questionable relevance of the data obtained. A prospective randomized study of systemic chemotherapy with or without RFHT in patients with colorectal hepatic metastases is in progress.",
author = "Moffat, {Frederick L} and T. Gilas and K. Calhoun and M. Falk and R. Dalfen and Rotstein, {L. E.} and L. Makowka and V. Howard and D. Laing and D. Venturi",
year = "1985",
month = "6",
day = "5",
doi = "10.1002/1097-0142(19850315)55:6<1291::AID-CNCR2820550623>3.0.CO;2-G",
language = "English",
volume = "55",
pages = "1291--1295",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Further experience with regional radiofrequency hyperthermia and cytotoxic chemotherapy for unresectable hepatic neoplasia

AU - Moffat, Frederick L

AU - Gilas, T.

AU - Calhoun, K.

AU - Falk, M.

AU - Dalfen, R.

AU - Rotstein, L. E.

AU - Makowka, L.

AU - Howard, V.

AU - Laing, D.

AU - Venturi, D.

PY - 1985/6/5

Y1 - 1985/6/5

N2 - The authors report on 178 patients with unresectable hepatic tumors who have been treated with 1 to 25 (median, 6) courses of radiofrequency hyperthermia (RFHT) and chemotherapy. In 137 patients, the hepatic tumors consisted of metastases from colorectal adenocarcinomas. For patients who had no previous therapy and who had colorectal metastases with no extrahepatic disease, cumulative survival at 52 weeks' follow-up was 80.5% and partial tumor regression was seen in 78.4%. Among the 69 patients who previously had conventional treatment for their hepatic disease, partial regression was seen in 43.5%. We are no longer monitoring tumor core temperature routinely, as the invasive methods currently in use yield irreproducible results; the risks to the patient cannot be justified in view of the questionable relevance of the data obtained. A prospective randomized study of systemic chemotherapy with or without RFHT in patients with colorectal hepatic metastases is in progress.

AB - The authors report on 178 patients with unresectable hepatic tumors who have been treated with 1 to 25 (median, 6) courses of radiofrequency hyperthermia (RFHT) and chemotherapy. In 137 patients, the hepatic tumors consisted of metastases from colorectal adenocarcinomas. For patients who had no previous therapy and who had colorectal metastases with no extrahepatic disease, cumulative survival at 52 weeks' follow-up was 80.5% and partial tumor regression was seen in 78.4%. Among the 69 patients who previously had conventional treatment for their hepatic disease, partial regression was seen in 43.5%. We are no longer monitoring tumor core temperature routinely, as the invasive methods currently in use yield irreproducible results; the risks to the patient cannot be justified in view of the questionable relevance of the data obtained. A prospective randomized study of systemic chemotherapy with or without RFHT in patients with colorectal hepatic metastases is in progress.

UR - http://www.scopus.com/inward/record.url?scp=0021922461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021922461&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19850315)55:6<1291::AID-CNCR2820550623>3.0.CO;2-G

DO - 10.1002/1097-0142(19850315)55:6<1291::AID-CNCR2820550623>3.0.CO;2-G

M3 - Article

C2 - 3971298

AN - SCOPUS:0021922461

VL - 55

SP - 1291

EP - 1295

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 6

ER -